Product Introduction:
Trivoglitor 0.2/500/2 Mg Tablet is a combination medication used for the management of Type 2 Diabetes Mellitus. It combines Voglibose, Metformin, and Glimepiride, which work together to control blood sugar levels by different mechanisms, improving glycemic control.
Uses:
-
Treatment of Type 2 diabetes
-
Controls fasting and postprandial blood sugar levels
-
Helps reduce symptoms and complications related to diabetes
Benefit:
-
Metformin decreases hepatic glucose production and improves insulin sensitivity
-
Glimepiride stimulates insulin secretion from pancreatic beta cells
-
Voglibose delays glucose absorption from the intestines, reducing post-meal glucose spikes
-
Synergistic action for effective blood glucose control
Composition (per tablet):
-
Voglibose 0.2 mg
-
Metformin Hydrochloride (Sustained Release) 500 mg
-
Glimepiride 2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal symptoms like nausea, vomiting, diarrhea, and abdominal discomfort
-
Flatulence and bloating due to Voglibose
-
Rare allergic reactions (rash, itching)
Consult a doctor if severe symptoms or hypoglycemia occur.
Safety Advice:
-
Take the tablet with meals to reduce gastrointestinal upset
-
Monitor blood glucose regularly
-
Avoid alcohol during treatment
-
Inform your doctor if you have kidney, liver, or heart disease
-
Not recommended during pregnancy and breastfeeding unless prescribed
